These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
188 related items for PubMed ID: 19827138
1. Pulmonary hypertension in children and young adults with sickle cell disease: evidence for familial clustering. Dahoui HA, Hayek MN, Nietert PJ, Arabi MT, Muwakkit SA, Saab RH, Bissar AN, Jumaa NM, Farhat FS, Dabbous IA, Bitar FF, Abboud MR. Pediatr Blood Cancer; 2010 Mar; 54(3):398-402. PubMed ID: 19827138 [Abstract] [Full Text] [Related]
2. Elevation of tricuspid regurgitant jet velocity, a marker for pulmonary hypertension in children with sickle cell disease. Ambrusko SJ, Gunawardena S, Sakara A, Windsor B, Lanford L, Michelson P, Krishnamurti L. Pediatr Blood Cancer; 2006 Dec; 47(7):907-13. PubMed ID: 16496290 [Abstract] [Full Text] [Related]
3. Pulmonary hypertension associated with sickle cell disease: clinical and laboratory endpoints and disease outcomes. De Castro LM, Jonassaint JC, Graham FL, Ashley-Koch A, Telen MJ. Am J Hematol; 2008 Jan; 83(1):19-25. PubMed ID: 17724699 [Abstract] [Full Text] [Related]
4. Proteinuria is associated with elevated tricuspid regurgitant jet velocity in children with sickle cell disease. Forrest S, Kim A, Carbonella J, Pashankar F. Pediatr Blood Cancer; 2012 Jun; 58(6):937-40. PubMed ID: 21990235 [Abstract] [Full Text] [Related]
5. Tricuspid regurgitant jet velocity is associated with hemolysis in children and young adults with sickle cell disease evaluated for pulmonary hypertension. Liem RI, Young LT, Thompson AA. Haematologica; 2007 Nov; 92(11):1549-52. PubMed ID: 18024403 [Abstract] [Full Text] [Related]
6. Pulmonary hypertension in children and adolescents with sickle cell disease. Onyekwere OC, Campbell A, Teshome M, Onyeagoro S, Sylvan C, Akintilo A, Hutchinson S, Ensing G, Gaskin P, Kato G, Rana S, Kwagyan J, Gordeuk V, Williams J, Castro O. Pediatr Cardiol; 2008 Mar; 29(2):309-12. PubMed ID: 17680298 [Abstract] [Full Text] [Related]
7. Prolonged QTc interval in children and young adults with sickle cell disease at steady state. Liem RI, Young LT, Thompson AA. Pediatr Blood Cancer; 2009 Jul; 52(7):842-6. PubMed ID: 19229972 [Abstract] [Full Text] [Related]
9. A prospective appraisal of pulmonary hypertension in children with sickle cell disease. Sedrak A, Rao SP, Miller ST, Hekmat V, Rao M. J Pediatr Hematol Oncol; 2009 Feb; 31(2):97-100. PubMed ID: 19194191 [Abstract] [Full Text] [Related]
10. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. Gladwin MT, Sachdev V, Jison ML, Shizukuda Y, Plehn JF, Minter K, Brown B, Coles WA, Nichols JS, Ernst I, Hunter LA, Blackwelder WC, Schechter AN, Rodgers GP, Castro O, Ognibene FP. N Engl J Med; 2004 Feb 26; 350(9):886-95. PubMed ID: 14985486 [Abstract] [Full Text] [Related]
11. Tricuspid regurgitant jet velocity elevation and its relationship to lung function in pediatric sickle cell disease. Liem RI, Nevin MA, Prestridge A, Young LT, Thompson AA. Pediatr Pulmonol; 2009 Mar 26; 44(3):281-9. PubMed ID: 19205056 [Abstract] [Full Text] [Related]
12. Hydroxyurea in sickle cell disease--a study of clinico-pharmacological efficacy in the Indian haplotype. Italia K, Jain D, Gattani S, Jijina F, Nadkarni A, Sawant P, Nair S, Mohanty D, Ghosh K, Colah R. Blood Cells Mol Dis; 2009 Mar 26; 42(1):25-31. PubMed ID: 18954999 [Abstract] [Full Text] [Related]
13. Effects of hydroxyurea treatment on cerebral oxygenation in adult patients with sickle cell disease: an open-label pilot study. Tavakkoli F, Nahavandi M, Wyche MQ, Castro O. Clin Ther; 2005 Jul 26; 27(7):1083-8. PubMed ID: 16154487 [Abstract] [Full Text] [Related]
14. Coagulation activation and inflammation in sickle cell disease-associated pulmonary hypertension. Ataga KI, Moore CG, Hillery CA, Jones S, Whinna HC, Strayhorn D, Sohier C, Hinderliter A, Parise LV, Orringer EP. Haematologica; 2008 Jan 26; 93(1):20-6. PubMed ID: 18166781 [Abstract] [Full Text] [Related]
15. Prevention of secondary stroke and resolution of transfusional iron overload in children with sickle cell anemia using hydroxyurea and phlebotomy. Ware RE, Zimmerman SA, Sylvestre PB, Mortier NA, Davis JS, Treem WR, Schultz WH. J Pediatr; 2004 Sep 26; 145(3):346-52. PubMed ID: 15343189 [Abstract] [Full Text] [Related]
16. A two-year pilot trial of hydroxyurea in very young children with sickle-cell anemia. Wang WC, Wynn LW, Rogers ZR, Scott JP, Lane PA, Ware RE. J Pediatr; 2001 Dec 26; 139(6):790-6. PubMed ID: 11743503 [Abstract] [Full Text] [Related]
17. Sickle-cell anemia and pulmonary hypertension. Ninkovich GM, Miller SK, Alpert PT. J Am Acad Nurse Pract; 2010 Apr 26; 22(4):198-204. PubMed ID: 20409257 [Abstract] [Full Text] [Related]
18. The presence of alpha-thalassaemia trait blunts the response to hydroxycarbamide in patients with sickle cell disease. Vasavda N, Badiger S, Rees D, Height S, Howard J, Thein SL. Br J Haematol; 2008 Nov 26; 143(4):589-92. PubMed ID: 18764867 [Abstract] [Full Text] [Related]
19. Effects of hydroxyurea in a population of Brazilian patients with sickle cell anemia. Vicari P, Barretto de Mello A, Figueiredo MS. Am J Hematol; 2005 Mar 26; 78(3):243-4. PubMed ID: 15726590 [Abstract] [Full Text] [Related]
20. A hemodynamic study of pulmonary hypertension in sickle cell disease. Parent F, Bachir D, Inamo J, Lionnet F, Driss F, Loko G, Habibi A, Bennani S, Savale L, Adnot S, Maitre B, Yaïci A, Hajji L, O'Callaghan DS, Clerson P, Girot R, Galacteros F, Simonneau G. N Engl J Med; 2011 Jul 07; 365(1):44-53. PubMed ID: 21732836 [Abstract] [Full Text] [Related] Page: [Next] [New Search]